|
Market Closed -
NSE India S.E.
07:05:10 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 1,922.90 INR | +0.50% |
|
+3.63% | +32.96% |
| Market Cap | 312B 3.28B 2.94B 2.72B 2.46B 4.6B 4.66B 32.54B 12.96B 164B 12.31B 12.05B 519B | P/E 2025 |
-472x | P/E 2026 | 89.7x |
|---|---|---|---|---|---|
| Enterprise Value | 328B 3.44B 3.09B 2.86B 2.59B 4.83B 4.89B 34.15B 13.6B 172B 12.92B 12.65B 545B | EV / Sales 2025 |
8.1x | EV / Sales 2026 | 5.97x |
| Free-Float |
48.99% | Yield 2025 * |
-
| Yield 2026 | - |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| WOCKPHARMA | Delayed | |
Bombay S.E.
| WOCKPHARMA | Delayed |
| 1 day | +0.50% | ||
| 1 week | +3.63% | ||
| Current month | -9.14% | ||
| 1 month | -12.36% | ||
| 3 months | +0.33% | ||
| 6 months | +38.17% | ||
| Current year | +32.96% |
| 1 week | 1,772 |  | 1,960.5 |
| 1 month | 1,772 | | 2,213.6 |
| Current year | 1,086.7 | | 2,422.3 |
| 1 year | 1,086.7 | | 2,422.3 |
| 3 years | 221.05 | | 2,422.3 |
| 5 years | 145.15 | | 2,422.3 |
| 10 years | 145.15 | | 2,422.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2009-03-31 | |
Deepak Madnani
DFI | Director of Finance/CFO | - | 2022-02-28 |
Mahesh V. Patel
CTO | Chief Tech/Sci/R&D Officer | - | 1998-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 2009-11-05 | |
| Director/Board Member | 53 | 2009-11-05 | |
| Director/Board Member | 55 | 1996-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.50% | +3.63% | +47.17% | +746.53% | 3.26B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| +0.75% | +2.35% | +54.11% | +66.31% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +3.13% | +3.38% | +35.27% | +57.44% | 294B | |
| +2.03% | +0.20% | +3.55% | +27.29% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +1.44% | +1.44% | +41.95% | +143.71% | 404.04B | |
| Weighted average by Cap. | +1.96% | +1.50% | +45.03% | +89.81% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 30.35B 319M 286M 264M 239M 447M 453M 3.16B 1.26B 15.88B 1.2B 1.17B 50.42B | 34.62B 364M 326M 302M 273M 510M 516M 3.61B 1.44B 18.12B 1.36B 1.34B 57.51B |
| Net income | -470M -4.93M -4.43M -4.09M -3.71M -6.93M -7.01M -48.94M -19.49M -246M -18.52M -18.13M -781M | 2.13B 22.36M 20.07M 18.55M 16.8M 31.39M 31.77M 222M 88.35M 1.11B 83.92M 82.15M 3.54B |
| Net Debt | 14.33B 150M 135M 125M 113M 211M 214M 1.49B 594M 7.5B 565M 553M 23.81B | 15.53B 163M 146M 135M 122M 229M 232M 1.62B 644M 8.13B 612M 599M 25.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | ₹1,922.90 | +0.50% | 496,528 |
| 26-10-28 | ₹1,913.40 | +1.52% | 490,596 |
| 26-10-27 | ₹1,884.80 | +4.16% | 524,659 |
| 26-10-26 | ₹1,809.60 | +0.44% | 798,653 |
| 26-10-23 | ₹1,801.70 | -2.90% | 879,190 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WOCKPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
